SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-096078
Filing Date
2023-12-15
Accepted
2023-12-15 16:07:24
Documents
1
Period of Report
2023-12-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1489
  Complete submission text file 0001213900-23-096078.txt   2778
Mailing Address 91 JAMES AVENUE ATHERTON CA 94027
Business Address
KING THOMAS BRAXTON (Reporting) CIK: 0001279309 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39102 | Film No.: 231490347

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Issuer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations